The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Ekusheva E.V.

Otdel patologii vegetativnoĭ nervnoĭ sistemy Nauchno-issledovatel'skogo tsentra Pervogo Moskovskogo gosudarstvennogo meditsinskogo universiteta im. I.M. Sechenova, Moskva

Artemenko A.R.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Osipova V.V.

Research Department of Neurology, Scientific Research Center, I.M. Sechenov First Moscow State Medical University, Moscow, Russia;
Moscow Research Clinical Centre for Neuropsychiatry, Moscow Health Department, Moscow, Russia

Diagnosis of refractory forms of chronic primary headache

Authors:

Ekusheva E.V., Artemenko A.R., Osipova V.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(1‑2): 48‑53

DOI: 10.17116/jnevro20171171248-53

Read: 3372 times

Download PDF (RU)
Contact the author
Table of contents

DIAGNOSIS OF REFRACTORY FORMS OF CHRONIC PRIMARY HEADACHE
DIAGNOSIS OF REFRACTORY FORMS OF CHRONIC PRIMARY HEADACHE

To cite this article:

Ekusheva EV, Artemenko AR, Osipova VV. Diagnosis of refractory forms of chronic primary headache. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(1‑2):48‑53. (In Russ.)
https://doi.org/10.17116/jnevro20171171248-53

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

A number of patients with primary headaches remain insensitive or refractory to treatment despite correctly selected drugs, adequate therapeutic dose and duration of therapy. The importance of refractory problem is determined by the fact that patients are completely maladjusted, disabled, and keeping these patients is very difficult even for seasoned professionals. Determination of the correct tactics and success of the treatment depends, in the first place, on the correct diagnosis. This article discusses the diagnostic criteria for the most important forms such as refractory chronic migraine or refractory chronic cluster headache presented by experts of the European Headache Federation in two separate Consensus.

Keywords:

refractory primary headaches
refractory migraine
refractory cluster headache
diagnostic criteria

Authors:

Ekusheva E.V.

Otdel patologii vegetativnoĭ nervnoĭ sistemy Nauchno-issledovatel'skogo tsentra Pervogo Moskovskogo gosudarstvennogo meditsinskogo universiteta im. I.M. Sechenova, Moskva

Artemenko A.R.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Osipova V.V.

Research Department of Neurology, Scientific Research Center, I.M. Sechenov First Moscow State Medical University, Moscow, Russia;
Moscow Research Clinical Centre for Neuropsychiatry, Moscow Health Department, Moscow, Russia

Close metadata

References:

  1. Natoli JL, Manack A, Dean B, Butler Q, Turkel CC, Stovner L, Lipton RB. Global prevalence of chronic migraine: а systematic review. Cephalalgia. 2010;30:599-609. doi:10.1111/j.1468-2982.2009.01941.x
  2. Steiner TJ, Birbeck GL, Jensen RH, Katsarava Z, Stovner LJ, Martelletti P. Headache disorders are third cause of disability worldwide. The Journal of Headache and Pain. 2015;16:58. doi:10.1186/s10194-015-0544-2
  3. Ayzenberg I, Katsarava Z, Sborowski A, Chernysh M, Osipova V, Tabeeva G, Yakhno N, Steiner TJ. The prevalence of primary headache disorders in Russia: A countrywide survey. Cephalalgia. 2012;32(5):373-381. doi:10.1177/0333102412438977
  4. Global, regional, and national age—sex specific all-cause and cause-specific mortality for 240 causes of death, 1990—2013: a systematic analysis for the Global Burden of Disease Study 2013 GBD 2013 Mortality and Causes of Death Collaborators. Lancet. 2015;385:117. doi:10.1016/S0140-6736(14)61682-2
  5. Stovner LJ, Zwart JA, Hagen K, Terwindt GM, Pascual J. Epidemiology of headache in Europe. European Journal of Neurology. 2006;13:333-345. doi:10.1111/j.1468-1331.2006.01184.x
  6. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808. doi:10.1177/0333102413485658
  7. Artemenko AR, Kurenkov AL. Chronic migraine. М.: ID «ABV-press»; 2012. (In Russ.).
  8. Bloudek LM, Stokes M, Buse DC, Wilcox TK, Lipton RB, Goadsby PJ, Varon SF, Blumenfeld AM, Katsarava Z, Pascual J, Lanteri-Minet M, Cortelli P, Martelletti P. Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS). The Journal of Headache and Pain. 2012;13:361-378. doi:10.1007/s10194-012-0460-7
  9. Glembotskaya GT, Kozub OV. Pharmacoeconomic evaluation of the «burden» of migraine in the Russian Federation. Clinical pharmacology and therapy. 2013;22(2):83-86. (In Russ.).
  10. Lipton RB. Chronic migraine, classification, differential diagnosis, and epidemiology. Headache. 2011;51(suppl 2):77-83. doi:10.1111/j.1526-4610.2011.01954.x
  11. The International Classification of Headache Disorders, 2rd edition (full russian version). Translation from English Osipova V.V. 2006. (In Russ.).
  12. Amelin AV, Ignatov YD, Skoromec AA, Sokolov AY. Migraine (pathogenesis, clinical features, treatment). М.: MEDpress; 2011. (In Russ.).
  13. Osipova VV. Migraine and tension-type headache. In: Clinical guidelines. Neurology and Neurosurgery. Eds. Gusev E.I., Konovalov A.N. 2 nd ed., Revised. and ext. M.: GEOTAR Media; 2015. (In Russ.).
  14. Osipova VV, Tabeeva GR. Primary headaches: diagnostics, clinic, therapy: A Practical Guide. М.: OOO «Publisher» Medical News Agency»; 2014. (In Russ.).
  15. Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population: Burden, diagnosis, and satisfaction with treatment. Neurology. 2008;71:559-566. doi:10.1212/01.wnl.0000323925.29520.e7
  16. Evans RW. A rational approach to the management of chronic migraine. Headache. 2013;53:168-176. doi:10.1111/head.12014
  17. Schulman EA, Lake АE, Goadsby PJ, Peterlin BL, Siegel SE, Markley HG, Lipton RB. Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society. Headache. 2008;48:778-782. doi:10.1111/j.1526-4610.2008.01132.x
  18. Azimova YE. Refractory migraine. Pharmateka. 2012;12:50-53. (In Russ.).
  19. Ekusheva EV, Damulin IV. The actual approaches to therapy of refractory migraine. Russian Medical Journal. 2014;5:45-52. (In Russ.).
  20. Tabeeva GR, Azimova YE, Margulis MI. Refractory migraine: from pathogenesis to rational therapy. Russian Medical Journal. 2011;1:18-19. (In Russ.).
  21. Irimia P, Palma JA, Fernandez-Torron R, Martinez-Vila E. Refractory migraine in a headache clinic population. BioMed Central Neurology. 2011;11:94. doi:10.1186/1471-2377-11-94
  22. Robbins L. Refractory chronic migraine: longterm follow-up using a refractory rating scale. The Journal of Headache and Pain. 2012;13:225-229. doi:10.1007/s10194-012-0423-z
  23. Martelletti P, Katsarava Z, Lampl C, Magis D, Bendtsen L, Negro A, Russell MB, Mitsikostas DD, Jensen RH. Refractory chronic migraine: a consensus statement on clinical definition from the European Headache Federation. The Journal of Headache and Pain. 2014;15:47. doi:10.1186/1129-2377-15-47
  24. Mitsikostas DD, Edvinsson L, Jensen RH, Katsarava Z, Lampl C, Negro A, Osipova V, Paemeleire K, Siva A, Valade D, Martelletti P. Refractory chronic cluster headache: a consensus statement on clinical definition from the European Headache Federation. The Journal of Headache and Pain. 2014;15:79. doi:10.1186/1129-2377-15-79
  25. Reisman EE. The use of experimental suppositories in treating refractory migraine. American Practitioner and Digest Treatment. 1952;3(4):308-310.
  26. Callaham M, Raskin N. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache. 1986;26:168-171. doi:10.1111/j.1526-4610.1986.hed2604168.x
  27. Nagy AJ, Gandhi S, Bhola R, Goadsby P. Intravenous dihydroergotamine for inpatient management of refractory primary headaches. Neurology. 2011;77:1827-1832. doi:10.1212/WNL.0b013e3182377dbb
  28. Tepper SJ, Tepper DE. The Cleveland clinic manual of headache therapy. Spring Science & Business Media. 2011.
  29. Ekusheva EV. Optimal approaches to treatment of migraine. Russian Medical Journal. 2012;10:522-528. (In Russ.).
  30. Schulman EA, Traumuta G. Refractory headache. Headache. 1993;33:273-286.
  31. Lake AE, Saper JR, Hamel RL. Comprehensive inpatient treatment of refractory chronic daily headache. Headache. 2009;49:555-562. doi:10.1111/j.1526-4610.2009.01364.x
  32. Hong J, Roberts DW. The surgical treatment of headache. Headache. 2014;54:409-429. doi:10.1111/head.12294
  33. Palmisani S, Al-Kaisy A, Arcioni R, Smith T, Negro A, Lambru G, Bandikatla V, Carson E, Martelletti P. A six year retrospective review of occipital nerve stimulation practice — controversies and challenges of an emerging technique for treating refractory headache syndromes. The Journal of Headache and Pain. 2013;14(1):67. doi:10.1186/1129-2377-14-67
  34. Levin М, Schulman Е. Refractory migraine: definition and classification. In: Refractory migraine: mechanisms and management. Eds. Schulman E.A., Levin M., Lake A.E., Loder E. New York: Oxford University Press; 2010.
  35. Lipton RB, Bigal ME. Epidemiology of refractory migraine. In Refractory migraine: mechanisms and management. Eds. Schulman E.A., Levin M., Lake A.E., Loder E. New York: Oxford University Press; 2010.
  36. Saper JR, Dodick D, Silberstein SD, McCarville S, Sun M, Goadsby PJ. Investigators ONSTIM Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia. 2011;31(3):271-285. doi:10.1177/0333102410381142
  37. Schulman EA, McGeeney BE. Current concepts in refractory migraine. Current Treatment Opitions in Neurology. 2013;15(1):40-55. doi:10.1007/s11940-012-0206-5
  38. Goadsby PJ, Schoenen J, Ferrari MD, Silberstein SD, Dodick DW. Towards a definition of intractable headache for use in clinical practice and trials. Cephalalgia. 2006;26:1168-1170. doi:10.1111/j.1526-4610.2010.01764.x
  39. D'Amico D, Leone M, Grazzi L, Bussone G. When should «chronic migraine» patients be considered «refractory» to pharmacological prophylaxis? Neurological Sciences. 2008;29:55-58. doi:10.1111/j.1526-4610.2010.01764.x
  40. Ekusheva EV, Damulin IV. Refractory migraine: modern methods of drug therapy. Neurological Gazette them Bekhterev. 2014;46(4):44-52. (In Russ.).
  41. Pompili M, Serafini G, Di Cosimo D, Dominici G, Innamorati M, Lester D, Forte A, Girardi N, De Filippis S, Tatarelli R, Martelletti P. Psychiatric comorbidity and suicide risk in patients with chronic migraine. Journal of Neuropsychiatric Disease and Treatment. 2010;6:81-91. doi:10.2147/NDT.S8467
  42. Dodick DW, Turkel CC, DeGryse R, Aurora SK, Silberstein SD, Lipton RB, Diener H-C, Brin MF. Onabotulinumtoxin A for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 2010;50:921-936. doi:10.1111/j.1526-4610.2010.01678.x
  43. Wöber C, Wessely P. Comment on: Martelletti P., Katsarava Z., Lampl C., Magis D., Bendtsen L., Negro A., Russell M.B., Mitsikostas D.D., Jensen R.H. Refractory chronic migraine: a consensus statement on clinical definition from the European Headache Federation. The Journal of Headache and Pain. 2014;15:77. doi:10.1186/1129-2377-15-77
  44. Tabeeva GR, Yakhno NN. Migraine. M.: GEOTAR-Media; 2011. (In Russ.).
  45. Mathew NT. Prophylactic treatment of refractory migraine. In Refractory migraine: mechanisms and management. Eds. Schulman E.A., Levin M., Lake A.E., Loder E. New York: Oxford University Press; 2010.
  46. Artemenko AR, Kurenkov AL, Antipova OS. Diagnosis and treatment of chronic migraine. М.: Hot line — Telekom; 2014;204. (In Russ.).
  47. Pain (practical guide for physicians). Eds. Yakhno NN, Kukuchkin ML. M.: Publisher of Medical Sciences; 2011. (In Russ.).
  48. Artemenko AR, Kurenkov AL, Belomestova KV. Classification, diagnosis and treatment of chronic migraine: review of new data. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2013;11:91-96. (In Russ.).
  49. Artemenko AR, Osipova VV, Filatova EG, Naprienko MV, Azimova YE, Boiko AN, Kostenko EV, Lebedeva AV. Primary chronic headaches (diagnostics, clinic, therapy). Guidelines №26. Moscow City Government, Department of Health. Mo. 2014;28. (In Russ.).
  50. Silberstein SD, Dodick DW, Saper J, Huh B, Slavin KV, Sharan A, Reed K, Narouze S, Mogilner A, Goldstein J, Trentman T, Vaisma J, Ordia J, Weber P, Deer T, Levy R, Diaz RL, Washburn SN, Mekhail N. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, doubleblinded, controlled study. Cephalalgia. 2012;32:1165-1179. doi:10.1177/0333102412462642
  51. Schoenen J, Jensen RH, Lanteri-Minet M. Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled study. Cephalalgia. 2013;33:816-830. doi:10.1177/0333102412473667
  52. Jürgens TP, Barloese M, May A, Láinez JM, Schoenen J, Gaul C, Goodman AM, Caparso A, Jensen RH. Long-term effectiveness of sphenopalatine ganglion stimulation for cluster headache. Cephalalgia. 2016. doi:10.1177/0333102416649092
  53. Sillay KA, Sani S, Starr PA. Deep brain stimulation for medically intractable cluster headache. Neurobiology of Disease. 2010;38:361-368.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.